Autolomous

#Autolomous #Cell and gene therapy #Cell and Gene Therapy Catapult #Digitalisation #Funding

CGT grant funds implementation and digitisation of PAT  

Autolomous, a developer of critical manufacturing management systems for cell and gene therapies (CGTs), and the Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of CGTs, have been awarded a joint £1.2 million grant by UK Research and Innovation (UKRI),… Read More

#News